Document is current
Any future updates will be listed below
-
Authors
Inoki, Yuta
Horinouchi, Tomoko https://orcid.org/0000-0003-1655-6030
Aoyama, Shuhei
Kimura, Yuka
Ichikawa, Yuta
Tanaka, Yu
Ueda, Chika
Kitakado, Hideaki
Kondo, Atsushi
Sakakibara, Nana
Kamei, Koichi
Hamada, Riku
Fujita, Naoya
Gotoh, Yoshimitsu
Kaku, Yoshitsugu
Nishiyama, Kei
Okamoto, Takayuki
Toya, Yukiko
Yamamura, Tomohiko
Ishimori, Shingo
Nagano, China
Nozu, Kandai
-
Funding
Funding for this research was provided by:
Kobe University
- License Information
-
More Information
Article History
Received: 12 October 2024
Revised: 7 February 2025
Accepted: 21 February 2025
First Online: 17 March 2025
Declarations
:
: This study was approved by the Institutional Review Board of Kobe University School of Medicine (IRB approval number: 301). All procedures in this study were conducted in accordance with the Declaration of Helsinki and the ethical guidelines of the Japanese Ministry of Health, Labour, and Welfare.
: Informed consent was obtained from all patients or their family members.
: Kandai Nozu is a member of the advisory groups of Kyowa Kirin Co. Ltd., Toa Eiyo Ltd., and Taisho Pharmaceutical Co. Ltd. Kandai Nozu received speaker grants from Sumitomo Pharma Co., Ltd., Chugai Pharmaceutical Co., Ltd., and Kyowa Kirin Co., Ltd. The other authors declare that they have no competing interests.
